| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sagimet Biosciences Inc. | Chief Medical Officer | Series A Common Stock | 107K | $340K | $3.18 | Jul 21, 2025 | Direct |
| Sagimet Biosciences Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 138K | Feb 6, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SGMT | Sagimet Biosciences Inc. | Jul 21, 2025 | 1 | -$75.6K | 4 | Jul 23, 2025 | Chief Medical Officer |
| SGMT | Sagimet Biosciences Inc. | Feb 6, 2025 | 2 | $0 | 4 | Feb 7, 2025 | Chief Medical Officer |
| SGMT | Sagimet Biosciences Inc. | Jul 19, 2024 | 1 | -$25.9K | 4 | Jul 23, 2024 | Chief Medical Officer |
| SGMT | Sagimet Biosciences Inc. | Nov 17, 2023 | 1 | $0 | 4 | Nov 21, 2023 | Chief Medical Officer |
| SGMT | Sagimet Biosciences Inc. | Jul 18, 2023 | 4 | $0 | 4 | Jul 20, 2023 | Chief Medical Officer |
| SGMT | Sagimet Biosciences Inc. | Jul 13, 2023 | 0 | $0 | 3 | Jul 13, 2023 | Director |